✦ LIBER ✦

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal

✍ Scribed by A.C. Palma; F. Araújo; V. Duque; F. Borges; M.T. Paixão; R. Camacho

Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 253 KB
Volume: 7
Category: Article
ISSN: 1567-1348
DOI: 10.1016/j.meegid.2007.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low prevalence of transmitted drug resis

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia

✍ Dace Balode; Maj Westman; Tatjana Kolupajeva; Baiba Rozentale; Jan Albert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as

Molecular epidemiology of HIV-1 subtypes

Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan

✍ Yu-Ching Lan; Tarek Elbeik; JoAnn Dileanis; Valerie Ng; Yen-Ju Chen; Hsieh-Shong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract The Taiwanese government has provided free highly active antiretroviral therapy since April 1997. Previously, we have reported on the molecular epidemiology of HIV‐1 in Taiwan from 1988 to 1998. In addition, an outbreak of circulating recombinant form (CRF) 07\_BC among intravenous drug

Replicative fitness in vivo of HIV-1 var

Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations

✍ Helen L. Devereux; Vincent C. Emery; Margaret A. Johnson; Clive Loveday 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract The relative fitness of HIV‐1 viral variants containing a broad range of drug resistance‐associated mutations has been little studied in vivo. Understanding the relative fitness associated with viruses containing mutations may aid future therapeutic management. The aim of this study was

Drug resistance mutations and newly reco

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an

Emergence and clinical relevance of muta

Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients

✍ E. J. Calderón; Y. Torres; F. J. Medrano; F. Luque; B. Larder; C. Rey; A. Sánche 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 955 KB

An in-house HIV genotyping assay for the

An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1

✍ Chun Kiat Lee; Hong Kai Lee; Tze Ping Loh; Sunil Kumar Sethi; Evelyn Siew-Chuan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Genotyping for HIV drug resistance is costly and beyond the means for many Southeast Asian patients, who are self‐funded. This prompted the development of a more cost‐effective, in‐house assay for an ethnically diverse, Southeast Asian population at the National University Hospital in S